| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0008 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |